Wird geladen...
Dalbavancin Use for the Treatment of Methicillin-resistant Staphylococcus aureus Pneumonia
Dalbavancin is a lipoglycopeptide with a long half-life that allows infrequent dosing. It is indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible organisms, including Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). Although this ag...
Gespeichert in:
| Veröffentlicht in: | J Pharmacol Pharmacother |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497404/ https://ncbi.nlm.nih.gov/pubmed/28706403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jpp.JPP_2_17 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|